RTLGenomics (original) (raw)

About

RTL Genomics has extensive experience helping our clients plan and successfully complete their research projects. We bridge the gap between concept and publication and are here to help you discover the diversity in your sample, its functional attributes, and how patterns of variation are explained by experimental design and sample source. We offer outstanding expertise for a variety of targeted gene and shotgun sequencing applications and are unmatched in available levels of analytical support.

Our History

Initially founded in 2004 to develop diagnostic techniques for infectious disease care using molecular approaches (qPCR and DNA sequencing) rather than culture, the company set a road map for the future of best practices in the field. Leveraging the early acquisition of some of the first next-generation sequencing platforms, RTL was one of the first commercial providers of 16S amplicon sequencing which revolutionized metagenomics and microbial ecology.

As next-generation sequencing technologies have evolved, so have we. We have operated all major sequencing platforms to come to market. Today, being an Illumina Certified Service Provider and PacBio Service Provider, we focus on providing the most data as quickly as possible to drive scientific discovery. Our PacBio Sequel IIe and Illumina MiSeq and NovaSeq platforms enable us to tackle projects of any size and across a wide range of scale of sequencing depth.

In 2020, RTL Genomics was acquired by its sister company MicroGen Diagnostics deepening the resources and technical capabilities of both companies.

We are excited to continue to be at the forefront of scientific discovery with our research partners.